EDC Data Management for pharmaceutical, biotechnology, and medical device companies

Body Header About

About Veristat

Veristat is an independently owned clinical research organization (CRO) located just outside of Boston. The company was founded in 1994 by John Balser, PhD, and Barbara Balser, VMD, with the intent of providing high-level statistical and medical consulting services to the pharmaceutical and biotechnology industries. Today, Veristat has steadily grown to over 78 experienced employees, providing comprehensive clinical and analytical research services. However, Veristat remains a relatively small company by design, enabling the company's principal staff to continue to work closely with our clients on an individualized basis.

Our clients range from small to large global companies, engaged in the development of new pharmaceutical and biological products, vaccines, medical devices, and diagnostic agents. Veristat’s client base has progressively grown largely based on industry referrals and the company’s commitment to client-focused services.

Sitemap Section Divider

Why Choose Veristat

There are several advantages to choosing Veristat.

  • We are flexible and scalable to our client's needs and offers diverse therapeutic expertise.
  • In our diverse sponsor partnerships, we have proven to be adaptable and accommodating, which is reflected in our client satisfaction and retention.
  • We are leaders in utilizing the latest technology platforms to assist sponsors in the challenges of adhering to new industry standards.
  • We are committed to providing quality services adhering to the highest ethical and scientific standards that meet or exceed the expectations of our clients.
Sitemap Section Divider

Mission

Mission

Our mission is to assist our clients in the development of innovative therapeutic, medical device, and diagnostic products that sustain and improve life, by providing clinical research services in an efficient and cost-effective manner, using scientific principles and state-of-the-art technology.